Jun 4, 2026 07:01AM
Jun 4, 2026 07:00AM
May 11, 2026 04:01PM
Mar 31, 2026 07:00AM
Mar 31, 2026 07:00AM
Mar 17, 2026 04:00PM
Jan 12, 2026 07:06AM AN2 Therapeutics receives FDA clearance for M. abscessus lung disease trial
Jan 12, 2026 07:00AM
Nov 12, 2025 04:01PM
Nov 10, 2025 07:00AM
Nov 10, 2025 07:00AM
Aug 12, 2025 04:01PM
Aug 12, 2025 07:02AM
Aug 12, 2025 07:00AM AN2 Therapeutics Commences First-in-Human Clinical Trial of Oral AN2-502998 for Chagas Disease
Jul 23, 2025 07:00AM
Jul 23, 2025 07:00AM
Jun 30, 2025 07:02AM
Jun 30, 2025 07:00AM
May 13, 2025 04:01PM
May 1, 2025 04:00PM
May 1, 2025 04:00PM AN2 Therapeutics Reports Data from the Phase 3 Portion of Previously Terminated EBO-301 Study and Outlines Future Milestones from Boron Chemistry Pipeline
Mar 26, 2025 04:06AM
Mar 26, 2025 01:46AM
Mar 25, 2025 04:00PM
Feb 24, 2025 07:03AM
Feb 24, 2025 07:00AM
Feb 20, 2025 04:07AM
Feb 3, 2025 04:13AM JMP Securities Reiterates Market Outperform Rating on AN2 Therapeutics (ANTX)
Jan 28, 2025 05:42AM
Nov 18, 2024 02:43AM
Nov 13, 2024 04:00PM
Oct 17, 2024 07:03AM
Oct 17, 2024 07:00AM
May 14, 2024 04:01PM
Apr 2, 2024 03:37AM JMP Securities Upgrades AN2 Therapeutics (ANTX) to Market Outperform
Mar 28, 2024 04:10PM
Feb 12, 2024 06:45AM
Feb 12, 2024 06:45AM
Nov 9, 2023 04:05PM
Oct 11, 2023 12:01AM
Sep 13, 2023 07:00AM
Aug 10, 2023 04:10PM AN2 Therapeutics Reports Second Quarter 2023 Financial Results and Recent Highlights
Jul 5, 2023 07:18PM
Mar 29, 2023 04:01PM
Mar 24, 2023 01:18AM
Nov 9, 2022 04:05PM
Aug 11, 2022 04:10PM
Jun 29, 2022 07:00AM
May 10, 2022 04:10PM AN2 Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates
Mar 4, 2022 04:10PM

323,729 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All